Literature DB >> 1835620

Determinants of prognosis in advanced colorectal cancer.

W Graf1, B Glimelius, L Påhlman, R Bergström.   

Abstract

The relations between patient characteristics and prognosis were examined in 340 patients with advanced colorectal cancer treated with chemotherapy. Variables were tested for relation to survival and responses in univariate and multivariate analyses. Performance status (P less than 0.001), number of symptoms (P less than 0.001) and haemoglobin level (P less than 0.001) were the most important variables for survival in univariate analyses. In the multivariate analyses of survival, haemoglobin level (P less than 0.001) and disease-free interval (P less than 0.01) were the most influential variables. In addition, number of symptoms (P less than 0.01), performance status (P less than 0.05) and treatment of the primary tumour (P less than 0.05) were independently related to survival. The main independent determinant of response was haemoglobin level (P less than 0.01). Besides these pretreatment characteristics, type of chemotherapy regimen influenced both response rate and survival in multivariate analyses (P less than 0.001). We conclude that haemoglobin level, disease-free interval, symptoms and performance status are important prognostic factors in advanced colorectal cancer. The distribution of these variables may influence the results of clinical trials.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1835620     DOI: 10.1016/0277-5379(91)90307-y

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  14 in total

1.  A practical prognostic index for inoperable non-small-cell lung cancer.

Authors:  T Wigren; H Oksanen; P Kellokumpu-Lehtinen
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  When a colonoscopy becomes a duodenoscopy: a palliative treatment of a malignant sigmoidoduodenal fistula.

Authors:  Xaver Huber; Raoul A Droeser; Christine Bernsmeier; Philipp Kirchhoff
Journal:  BMJ Case Rep       Date:  2013-05-24

3.  Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases.

Authors:  Louise C Connell; Taryn M Boucher; Joanne F Chou; Marinela Capanu; Stephanie Maldonado; Nancy E Kemeny
Journal:  J Surg Oncol       Date:  2016-12-23       Impact factor: 3.454

4.  Baseline hemoglobin and liver function predict tolerability and overall survival of patients receiving radioembolization for chemotherapy-refractory metastatic colorectal cancer.

Authors:  Andrew S Kennedy; David Ball; Steven J Cohen; Michael Cohn; Douglas M Coldwell; Alain Drooz; Edward Ehrenwald; Samir Kanani; Fred M Moeslein; Charles W Nutting; Samuel G Putnam; Steven C Rose; Michael Savin; Sabine Schirm; Navesh K Sharma; Eric Wang
Journal:  J Gastrointest Oncol       Date:  2017-02

Review 5.  Prognostic and predictive response factors in colorectal cancer patients: between hope and reality.

Authors:  Chiara De Divitiis; Guglielmo Nasti; Massimo Montano; Rossella Fisichella; Rosario Vincenzo Iaffaioli; Massimiliano Berretta
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

Review 6.  [Clinical, pathological and molecular prognostic factors in colorectal carcinomas].

Authors:  S E Baldus
Journal:  Pathologe       Date:  2003-01-21       Impact factor: 1.011

7.  The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer.

Authors:  W Graf; L Påhlman; R Bergström; B Glimelius
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640

8.  Integrating patient reported measures as predictive parameters into decisionmaking about palliative chemotherapy: a pilot study.

Authors:  Anna Creutzfeldt; Anna Suling; Karin Oechsle; Anja Mehnert; Djordje Atanackovic; Melanie Kripp; Dirk Arnold; Alexander Stein; Julia Quidde
Journal:  BMC Palliat Care       Date:  2016-03-01       Impact factor: 3.234

9.  Pre-operative serum albumin and neutrophil-lymphocyte ratio are associated with prolonged hospital stay following colorectal cancer surgery.

Authors:  Rohit Gohil; Majed Rishi; Benjamin H L Tan
Journal:  Br J Med Med Res       Date:  2014-01-01

10.  Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study.

Authors:  H Mahteme; J Hansson; A Berglund; L Påhlman; B Glimelius; P Nygren; W Graf
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.